This inventor holds 1 USPTO granted patent. Top assignee: Mub Medical Solutions as. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Martin W Ronningen: Innovator in Suturing Technology
Introduction
Martin W Ronningen is a notable inventor based in Porsgrunn, Norway. He has made significant contributions to the field of medical technology, particularly in suturing devices. His innovative approach has led to the development of a unique suturing member that enhances surgical procedures.
Latest Patents
Ronningen holds a patent for a "Suture member, suturing needle and suturing device." This invention features an interrupted suture member that includes a flexible elongate member with a first end and an opposite second end. The design incorporates one or more detents for anchoring the suture member in soft tissue. Additionally, the second end has a movable locking member, allowing for the adjustment of force exerted on the tissue. The patent also describes a suture needle with a notch for holding an interrupted suture and a suturing insertion device that connects to the suturing needle.
Career Highlights
Martin W Ronningen is currently employed at Mub Medical Solutions, where he continues to innovate in the medical field. His work focuses on improving surgical techniques and outcomes through advanced suturing technologies.
Collaborations
Ronningen collaborates with talented individuals such as Ubbat Ocak and Erik Pavels Petersen, contributing to a dynamic team dedicated to medical advancements.
Conclusion
Martin W Ronningen's contributions to suturing technology exemplify his commitment to enhancing surgical practices. His innovative patent reflects a deep understanding of medical needs and a drive to improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile